IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q1 2024 Holdings

Filed 2024-05-14 | 6 holdings | $89.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Korro BIO Inc(KRRO)COM500946108$33.1M368,08536.9%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$27.3M928,96430.4%
Tourmaline BIO Inc(TRML)COM89157D105$17.0M741,69118.9%
Hillevax IncCOM43157M102$9.3M558,92310.4%
Ventyx Biosciences Inc(VTYX)COM92332V107$2.3M412,2252.5%
Kezar Life Sciences IncCOM49372L100$747.2K828,7110.8%